Search results
Results from the WOW.Com Content Network
Life Technologies Corporation was a biotech company founded in November 2008 through a US $6.7 billion merger of Invitrogen Corporation and Applied Biosystems Inc. The joint sales of the combined companies were about $3.5 billion; they had about 9,500 employees and owned more than 3,600 licenses and patents.
On April 27, 1999, [18] the shareholders of Perkin-Elmer Corporation approved the reorganization of Perkin-Elmer into PE Corporation, a pure-play life science company. [20] Each share of the Perkin-Elmer stock (PKN) was to be exchanged for one share and for + 1 ⁄ 2 of a share respectively of the two new common share tracking stocks for the ...
Target 2035 is a global effort or movement to discover open science, pharmacological modulator(s) for every protein in the human proteome by the year 2035. [ 1 ] [ 2 ] [ 3 ] The effort is led by the Structural Genomics Consortium with the intention that this movement evolves organically.
The company also acquired GIBCO (Grand Island Biological Company) as part of the Life Technologies acquisition. [30] In February 2015, the company announced it would acquire Advanced Scientifics for $300 million in a cash-deal. ASI designs manufactures, and delivers technologies used in bioprocessing. [31]
The business scope expanded significantly when it acquired the rival biotechnology and cell culture company Life Technologies in 2000; Life had been formed in 1983 when GIBCO (Grand Island Biological Company) which had been founded around 1960 in New York, merged with a reagent company called Bethesda Research Laboratories. The company ...
Target price may mean: A stock valuation at which a trader is willing to buy or sell a stock; Target pricing – the price at which a seller projects that a buyer ...
The 2045 Initiative has a roadmap for developing cybernetic immortality. [8] The Initiative has the goal for an avatar controlled by a "brain-computer" interface to be developed between 2015 and 2020, between 2020 and 2025 creating an autonomous life-support system for the human brain linked to a robot, between 2030 and 2035 creating a computer model of the brain and human consciousness with ...
Qube Research & Technologies (QRT) is a global quantitative investment management firm headquartered in London with additional offices in Europe and Asia. Background [ edit ]